Bitter gourd induces apoptosis in HL60 human leukemia cells and suppresses the production of inflammatory cytokine in RAW264.7 macrophage like cells

Nippon Shokuhin Kagaku Kogaku Kaishi

Volumn 53, Issue 8, 2006, Pages 408-415

  Kobori, Masuko ^a   Amemiya, Junko ^b   Sakai, Miho ^c   Shiraki, Mitoshi ^d   Sugishita, Hiroyuki ^d   Sakaue, Naoko ^e   Hoshi, Yoshikazu ^f   Yukizaki, Chizuko ^c  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

^b Fukushima Prefecture Agricultural Experiment Station   (Japan)

^c Miyazaki Prefectural Food Research and Development Center   (Japan)

^d Miyazaki Agricultural Experiment Station   (Japan)

^e ARIAKE NATIONAL COLLEGE OF TECHNOLOGY   (Japan)

^f TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); MOMORDICA CHARANTIA;

EID: 33750115568     PISSN: 1341027X     EISSN: None     Source Type: Journal    
DOI: 10.3136/nskkk.53.408     Document Type: Article

References (24)

1. Grover, J.K. and Yadav, S.P., Pharmacological actions and potential uses of Momordica charantia: a review. J. Ethnopharmacol., 93, 123-132 (2004).
2. Basch, E., Gabardi, S. and Ulbricht, C., Bitter melon (Momordica charantia): a review of efficacy and safety. Am. J. Health Syst. Pharm., 60, 356-359 (2003).
3. Scartezzini, P. and Speroni, E., Review on some plants of Indian traditional medicine with antioxidant activity. J. Ethnopharmacol., 71, 23-43 (2000).
4. Shibib, B.A., Khan, L.A. and Rahman, R., Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6- bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem. J., 292, 267-270 (1993).
5. Ahmed, I., Adeghate, E., Cummings, E., Sharma, A.K. and Singh, J., Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Mol. Cell. Biochem., 261, 63-70 (2004).
6. Virdi, J., Sivakami, S., Shahani, S., Suthar, A.C., Banavalikar, M.M. and Biyani, M.K., Antihyperglycemic effects of three extracts from Momordica charantia. J. Ethnopharmacol., 88, 107-111 (2003).
7. Miura, T., Itoh, Y., Iwamoto, N., Kato, M. and Ishida, T., Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice. Biol. Pharm. Bull., 27, 248-250 (2004).
8. Senanayake, G.V., Maruyama, M., Shibuya, K., Sakono, M., Fukuda, N., Morishita, T., Yukizaki, C., Kawano, M. and Ohta, H., The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats. J. Ethnopharmacol., 91, 257-262 (2004).
9. Jayasooriya, A.P., Sakono, M., Yukizaki, C., Kawano, M. Yamamoto, K. and Fukuda, N., Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. J. Ethnopharmacol., 72, 331-336 (2000).
10. Chen, Q., Chan, L.L. and Li, E.T., Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J. Nutr., 133, 1088-1093 (2003).
11. Vikrant, V., Grover, J.K., Tandon, N., Rathi, S.S. and Gupta, N., Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats. J. Ethnopharmacol., 76, 139-143 (2001).
12. Singh, A., Singh, S.P. and Bamezai, R., Momordica charantia (Bitter Gourd) peel, pulp, seed and whole fruit extract inhibits mouse skin papillomagenesis. Toxicol. Lett., 94, 37-46 (1998).
13. Ike, K., Uchida, Y., Nakamura, T. and Imai, S., Induction of interferon-gamma (IFN-gamma) and T helper 1 (Th1) immune response by bitter gourd extract. J. Vet. Med. Sci., 67, 521-524 (2005).
14. Manabe, M., Takenaka, R., Nakasa, T. and Okinaka, O., Induction of anti-inflammatory responses by dietary Momordica charantia L. (bitter gourd). Biosci. Biotechnol. Biochem., 67, 2512-2517 (2003).
15. Murakami, T., Emoto, A., Matsuda, H. and Yoshikawa, M., Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chem. Pharm. Bull., 49, 54-63 (2001).
16. Kimura, Y., Akihisa, T., Yuasa, N., Ukiya, M., Suzuki, T., Toriyama, M., Motohashi, S. and Tokuda H., Cucurbitane-type triterpenoids from the fruit of Momordica charantia. J. Nat. Prod., 68, 807-809 (2005).
17. Kohno, H., Yasui, Y., Suzuki, R., Hosokawa, M., Miyashita, K. and Tanaka, T., Dietary seed oil rich in conjugated linolenic acid from bitter melon inhibits azoxymethane-induced rat colon carcinogenesis through elevation of colonic PPARgamma expression and alteration of lipid composition. Int. J. Cancer, 110, 896-901 (2004).
18. Tsuzuki, T., Tokuyama, Y., Igarashi, M., Nakagawa, K., Ohsaki, Y., Komai, M. and Miyazawa, T., a-Eleostearic acid (9Z11E13E-18:3) is quickly converted to conjugated linoleic acid (9Z11E-18:2) in rats. J Nutr., 134, 2634-2639 (2004).
19. Dhar, P., Ghosh, S. and Bhattacharyya, D.K., Dietary effects of conjugated octadecatrienoic fatty acid (9 cis, 11 trans, 13 trans) levels on blood lipids and non-enzymatic in vitro lipid peroxidation in rats. Lipids, 34, 109-114 (1999)
20. Noguchi, R., Yasui, Y., Suzuki, R., Hosokawa, M., Fukunaga, K. and Miyashita, K., Dietary effects of bitter gourd oil on blood and liver lipids of rats. Arch. Biochem. Biophys., 396, 207-212 (2001).
21. Tsuzuki, T., Tokuyama, Y., Igarashi, M. and Miyazawa, T., Tumor growth suppression by alpha-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation. Carcinogenesis, 25, 1417-1425 (2004).
22. Hasegawa, H., Sung, J.H., Matsumiya, S. and Uchiyama, M., Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 62, 453-457 (1996)
23. Hu, J., Reddy, M.B., Hendrich, S. and Murphy, A., Soyasaponin I and sapogenol B have limited absorption by Caco-2 intestinal cells and limited bioavaiability in women. J. Nutr. 134, 1867-1873 (2004).